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Abstract
Background: Gastric carcinoma is the second commonest cause of cancer deaths worldwide. Early detection and
diagnosis of gastric cancer in the stomach is important for improving the prognosis of gastric cancer. This
retrospective study was designed to investigate the value of magnifying narrow-band imaging (NBI) in the
diagnosis of precancerous lesions and early gastric cancer.
Methods: This study included 122 patients who were diagnosed with early gastric cancer or precancerous gastric
lesions by endoscopy. The patients underwent an examination with conventional endoscopy, magnifying NBI, and
magnifying chromoendoscopy. Images resolution was evaluated, and the morphology, pit patterns and blood
capillary forms of lesions were analyzed. The presence of gastric carcinoma and high grade intraepithelial neoplasia
in the biopsy samples was considered as a positive pathological result, which is used to assess accuracy of
endoscopic diagnosis.
Results: For image resolution, magnifying NBI and magnifying chromoendoscopy were significantly superior to
magnifying conventional endoscopy in morphology, pit pattern and blood capillary form (P < 0.01), and
magnifying NBI was significantly superior to magnifying chromoendoscopy in blood capillary form (P < 0.01). IV, V1,
and VI type of gastric pit pattern were detected in 14 cases, 43 cases, and 17 cases in patients with high grade
intraepithelial neoplasia, respectively. V1 and VI type of gastric pit pattern were detected in 9 cases and 39 cases in
patients with early gastric cancer, respectively. The presence of irregular minute vessels and variation in the caliber
of vessels was found in 109 cases. The accuracy, sensitivity, specificity, false positive rate and false negative rate for
diagnosis of early gastric cancer and precancerous gastric lesions were 68.9%, 95.1%, 63.1%, 24.5%, and 32.4% for
conventional endoscopy, 93.6%, 92.7%, 94.5%, 5.7%, and 6.9% for magnifying NBI, and 91.3%, 88.6%, 93.2%, 13.2%,
and 21.48% for magnifying chromoendoscopy, respectively.
Conclusions: This study demonstrates that magnifying NBI is superior to conventional endoscopy in the diagnosis
of early gastric cancer and precancerous gastric lesions, and can be used for screening early malignancies of the
stomach.
Background
Gastric carcinoma is one of the most common malig-
nant tumors, and is the second commonest cause of
cancer deaths worldwide [1]. About 870000 new gastric
cancer cases are diagnosed every year on a global scale.
There is a considerable geographical variation in the
incidence of this cancer [2]. It is reported that incidence
rates are high in eastern Asia, and low in Europe, North
America and Africa [1]. Chinese have high gastric can-
cer rates with about 30% new cases diagnosed each year,
which are only less than those found in Korea and
Japan [3]. The prognosis of gastric carcinoma is closely
related to the stage of disease at the time of diagnosis.
The survival rate is greater than 90% in 5 years [4] for
early gastric cancer, but the prognosis is very poor for
advanced gastric cancer. Therefore, early diagnosis of
gastric cancer is very important for an excellent prog-
nosis. However, since most patients with early gastric
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carcinoma do not have specific symptoms, it is difficult
to distinguish early gastric carcinoma from benign pep-
tic ulcer or gastritis, and only about 10-20% of gastric
cancers are diagnosed as early cancers in many coun-
tries [3]. With the development of technology, some
endoscopic imaging modalities, such as magnifying nar-
row-band imaging (NBI) endoscopy, have been used
recently for the diagnosis of early gastric cancer.
Although many studies have reported that this endo-
scopic imaging modality can increase the rate of diagno-
sis of early cancers and precancerous lesions by
enhancing visualization [5,6], there are few studies about
comparison between NBI and conventional endoscopy.
This retrospective study was designed to compare the
accuracy and sensitivity of magnifying NBI endoscopy
with conventional endoscopy and chromoendoscopy for




This retrospective study was performed in the Depart-
ment of Gastroenterology, Dalian Central hospital. Dur-
ing January 2008 to January 2011, a total of 14389
patients underwent endoscopic examination, and 526
lesions were detected. Among them, 122 patients were
diagnosed as early gastric cancer or precancerous gastric
lesions by the pathologic results, and were enrolled in
this retrospective study. The ages of the122 patients (83
males and 39 females) ranged from 16 to 94 years with
a mean age of 63.5 ± 14.1 years. Early gastric cancer
was defined as cancer confined to the mucosa or sub-
mucosa regardless of lymph node metastasis. In our
study, precancerous lesions referred to high grade
intraepithelial neoplasia, which included intraepithelial
carcinoma and severe dysplasia according to the Vienna
classification of gastrointestinal epithelial neoplasms [7].
All the lesions were confirmed by pathologic diagnosis
of endoscopic resection or post-surgery tissue. Exclusion
criteria were pre-existing or advanced gastric cancer,
recent upper gastrointestinal bleeding or coagulation
disorders, and severe comorbidities that may affect tol-
erance to upper endoscopy. The presenting manifesta-
tions were abdominal pain in 88 cases (72.1%),
distension in 52 cases (42.6%), heartburn in 60 cases
(49.2%), belching in 28 cases (23.0%), acid regurgitation
in 32 cases (26.2%), and nausea in 29 cases (23.8%).
Procedures
The patients were first given careful observation in
order to identify any abnormalities of the surface or
the color with conventional endoscopy. After detecting
lesions, magnifying chromoendoscopy and NBI magni-
fying endoscopy examination were followed on the
same day or on another day. The morphology, pit pat-
tern and blood capillary form of lesions were observed
and recorded to determine that the lesion was malig-
nant or benign (Figure 1). Then, biopsies were taken
and studied by the same expert pathologist. The image
quality was scored by two other endoscopists during
the examination. Pathological diagnosis was regarded
as the gold standard, and was used to assess accuracy
of endoscopic diagnosis. Once lesions were diagnosed
as gastric cancer or precancerous lesions, patients were
underwent endoscopic resection or surgery. This study
was approved by the Medical Science’s ethics commit-
tee of Dalian Central hospital, patients were informed
of the possible risks and benefits of participation in the
study, and written informed consent was obtained
from all the patients or their relatives before their
examination.
Instruments
The NBI main unit was an Olympus CV-260SL and the
endoscope was an Olympus GIF-H260Z (80×) (Olympus
Corporation, Japan); 1.2% iodine was used for staining
(Micro-Tech, Nanjing, CO., LTD).
Image evaluation
The image quality was scored as follow: 1 point:
obscure; 2 points: clouding; 3 points: more clear; and 4
points: clear [8].
Statistical analysis
Data analysis was performed using SPSS 10.0 software
(Chicago, IL, USA). Analysis of variance (ANOVA) or
Wilcoxon statistical methods were used to determine
statistical significance. All measurements in this study
were expressed as mean ± SD. P < 0.05 was considered
statistically significant.
Results
A total of 122 cases were diagnosed as early gastric can-
cer or precancerous lesions by pathologic diagnosis of
endoscopic resection or post-surgery tissue. The lesions
were located in gastric antrum in 67 cases (54.9%), gas-
tric angle in 29 cases (23.8%), gastric body in 22 cases
(18.0%), and cardia and gastric fundus in 4 cases (3.3%).
The image quality of 3 modes was compared concerning
the morphology, pit pattern and blood capillary form of
early gastric cancer and precancerous lesions. We found
that magnifying NBI and magnifying chromoendoscopy
were significantly superior to magnifying conventional
endoscopy in respect of morphology, pit pattern and
blood capillary form (P < 0.01), and magnifying NBI is
significantly superior to magnifying chromoendoscopy
in respect of blood capillary form (P < 0.01). There is
no significant difference between magnifying NBI and
Zhang et al. BMC Gastroenterology 2011, 11:135
http://www.biomedcentral.com/1471-230X/11/135
Page 2 of 7
magnifying chromoendoscopy with regard to morphol-
ogy and pit pattern (P > 0.05) (Table 1, Figure 2).
The gastric pit pattern is classified into six types
according to Sakaki [9]. In our studies, a total of 122
patients with early gastric cancer or precancerous gastric
lesions were diagnosed, including 74 cases of high grade
intraepithelial neoplasia and 48 cases of early gastric
cancer. In patients with high grade intraepithelial neo-
plasia, IV type of gastric pit pattern was detected in 14
cases, V1 type of gastric pit pattern was detected in 43
cases, and VI type of gastric pit pattern was detected in
17 cases; while in patients with early gastric cancer, V1
type of gastric pit pattern was detected in 9 cases, and
VI type of gastric pit pattern was detected in 39 cases.
Figure 1 Demonstration of gastric precancerous lesion with conventional endoscopy(A) and iodine staining pattern (B); Pit pattern of
this precancerous lesion with magnifying chromoendoscopy (C) and Blood capillary form with magnifying NBI (D).
Table 1 Comparison of image quality among three endoscopic modalities
item mode Score of image quality total score
1 2 3 4
conventional endoscopy 26 33 63 0 281
morphology magnifying NBI 0 0 12 110 476
magnifying chromoendoscopy 8 19 45 50 381
conventional endoscopy 26 62 34 0 190
pit pattern magnifying NBI 0 0 25 97 463
magnifying chromoendoscopy 0 0 40 82 448
conventional endoscopy 40 59 23 0 227
blood capillary form magnifying NBI 0 0 37 85 451
magnifying chromoendoscopy 38 57 27 0 233
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We also observed blood capillary form of gastric lesions.
The disappearance of the normal mucosa capillary net-
work or the presence of microvessels with irregular size,
shape and distribution were found in 109 cases.
The accuracy, sensitivity, specificity, false positive rate
and false negative rate of conventional endoscopic diag-
nosis for early gastric cancer and precancerous gastric
lesions were 68.9%, 95.1%, 63.1%, 24.5% and 32.4%,
respectively, while the corresponding values of magnify-
ing NBI were 93.6%, 92.7%, 94.5%, 5.7% and 6.9%,
respectively, and the corresponding values of magnifying
chromoendoscopy were 91.3%, 88.6%, 93.2%, 13.2% and
21.48%, respectively. Compared with conventional endo-
scopic, magnifying NBI was superior in the diagnosis of
early gastric cancer and precancerous gastric lesions.
However, there was no diagnostic difference between
magnifying NBI and magnifying chromoendoscopy.
Discussion
Gastric cancer is one of the main causes of cancer death
in China. Most of these patients have poor prognosis
because of late presentation and diagnosis. The best tac-
tics for dealing with gastric cancer is prevention, early
detection and early treatment. It is generally believed
that gastric cancer is a multi-step progression from
chronic gastritis to gastric atrophy, intestinal metaplasia,
dysplasia and cancer. Early gastric cancer is defined as a
cancer confined to the mucosa or submucosa regardless
of lymph node metastasis [10]. If gastric cancer can be
detected in early stage, the prognosis for gastric cancer
is excellent, the survival rate is greater than 90% in 5
years, and curative endoscopic resection may be possible
in some cases with early gastric cancers and precancer-
ous gastric lesions, without the need for surgery. There-
fore, it is necessary to mass screen for symptomatic
groups in high-incidence areas, and endoscopy has been
considered as one of the most useful tool for detecting
early gastric cancer. However, at present, only about 4-
10% of patients with gastric cancer are diagnosed as
early cancer in China, and the missed diagnosis of gas-
tric cancer on endoscopy is a common occurrence. It is
reported that the false-negative rates are high up to 5-
19% [11,12]. There may be two reasons for this situa-
tion. One reason is that the symptoms of early gastric
cancer are not specific to distinguish from those of gas-
tritis and benign peptic ulcer disease. In our group,
about 90% of patients with early gastric carcinoma have
heartburn, abdominal pain and discomfort in the upper
Figure 2 Comparition of image quality about morphology, pit pattern and blood capillary form among conventional endoscopy,
magnifying NBI and magnifying chromoendoscopy. A represent conventional endoscopy; B represent NBI; C represent chromoendoscopy.
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abdomen. The other reason is that some of the lesions
are so subtle that they are overlooked by inexperienced
endoscopist. Without being aware of early gastric can-
cer, they pay much attention to the detection of gross
lesions, rather than tiny changes in color, vascularity or
texture, which are distinctive characteristics of early gas-
tric cancer. There has been great advancement about
the technology of endoscopic imaging in recent years,
and these new technologies have improved the sensitiv-
ity in identifying early gastric cancer.
Magnifying endoscope (GIF-Q240Z) used in our study
can provide magnified images up to x80. This new mag-
nifying endoscope can detect minute changes of gastric
mucosal surface, such as the color of lesions (same
color as surrounding tissues, red or pale), the surface of
lesions (flat, elevated or depressed), the presence of
granules or nodules, with or without ulcer and fold
change. Irregular and destruction of the minute surface
pattern and color change of mucosal surface were all
considered as characteristics of precancerous gastric
lesion or early gastric cancer [13-15].
Dye spray chromoendoscopy can enhance the recogni-
tion of minute structural alteration caused by neoplastic
changes, which is difficult to be perceived by conventional
endoscopy. Magnifying chromoendoscopy is also useful in
observing the surface mucosal pattern and capillary struc-
ture. By analyzing the surface structure pattern, histologi-
cal changes of carcinoma, dysplasia, adenoma and
hyperplasia might be suspected. Since histopathological
examination of biopsy material is very important for the
final diagnosis, accurate biopsy contributes to acquire the
correct diagnosis of the lesion. Magnifying chromoendo-
scopy can improve the diagnosis of early gastric cancer
and precancerous lesions in the stomach by facilitating the
identification and biopsy of abnormal areas. It is difficult
in some cases to identify the margins of the lesions by
conventional endoscopy, especially those of superficial or
flat-type lesions. Magnifying chromoendoscopy has an
advantage in coping with this difficulty [13,16].
Narrow-band imaging (NBI) is a new kind of endo-
scopic technology designed to enhance the contrast of
the mucous membrane without staining. NBI uses spe-
cial narrow-band filters which filter broad-band spec-
trum to leave a narrow-band spectrum for the diagnosis
of digestive tract disease [17-19]. NBI endoscopy signifi-
cantly improves diagnostic accuracy in two ways. First,
because the shorter wavelength light left by the special
narrow-band filter can not penetrate deeply into the
mucosa, NBI improves visibility of mucosal pit pattern.
Second, since the specific wavelength 415 nm left by
special narrow-band filter corresponds to the peak
absorption spectrum for hemoglobin [20], magnifying
the image with NBI can give important information
about microvascular pattern [21].
In our study, we find that the image quality of magni-
fying NBI is superior not only to magnifying conven-
tional endoscopy in respect of morphology, pit pattern
and blood capillary form of abnormal areas, but also to
magnifying chromoendoscopy concerning blood capil-
lary form. However, in our study, the image quality was
scored during the examination, and the scoring system
itself has subjective nature, so it would be better to
score the image quality in a blinded fashion by more
investigators. We also find that the diagnotic accuracy
of early gastric cancer and precancerous gastric lesions
by magnifying NBI is significantly higher than that of
conventional endoscopy. Moreover, NBI has all the
functions that conventional endoscopy has, and the NBI
and conventional endoscopy pattern can be easily
switched just by pushing one button [22,23].
Both NBI and chromoendoscopy can show the
enhanced mucosal pattern and the microvascular struc-
ture of the mucosa by the amplificatory function[13],
and mucosal pattern and microvascular structure have
been regarded as distinctive characteristics of early gas-
tric cancer and precancerous gastric lesions.
It has been known that angiogenesis is an important
factor in gastrointestinal carcinogenesis [24], suggesting
that the vascular pattern of gastric cancer and precan-
cerous gastric lesion is differ from that of normal
mucosa [25]. Therefore, observation of vascular pattern
contributes to diagnosis of such lesions [26]. Nakayoshi
[5] et al observed the microvascular networks of 165
patients with early gastric carcinoma with magnifying
NBI, and found that 66.1% of differentiated adenocarci-
noma had fine microvascular networks, and 85.7% of
undifferentiated adenocarcinoma had corkscrew micro-
vascular networks. Liu [27] et al also drawn the conclu-
sion that vascular architecture was helpful in the
identification of early gastric cancer. They studied the
microvascular architecture with confocal endomicro-
scopy, and demonstrated that differentiated gastric can-
cerous mucosa showed hypervascularity and various
caliber microvessels with irregular shapes, and undiffer-
entiated gastric cancer showed hypovascularity and irre-
gular short branched vessels. In our study, we found
abnormal capillary patterns in 109 cases including disap-
pearance of the normal mucosa capillary network, tortu-
ous microvessels with irregular length and irregular
arrangement, and variation in the caliber of vessels or
even dilated microvessels with tortile tips. However, at
present, as a new technology, there is no unified stan-
dard for diagnosis of early gastric carcinoma by using
microvascular architecture.
Many studies have shown that gastric mucosa patterns
of gastric cancer and precancerous gastric lesions are
characteristic. Tanaka et al classified pit patterns of gas-
tric mucosa into five types, and pointed out that
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differentiated tubular adenocarcinomas mainly showed
the type IV, and poorly differentiated tubular adenocar-
cinomas mainly showed type V [17]. Yoshida et al dis-
tinguished gastric cancer and precancerous gastric
lesions from controls by analyzing the surface structure
pattern [28]. In our study, V1 and VI type of gastric pit
pattern are the most common mucosa pattern of early
gastric cancer and precancerous lesions. Therefore
determination of pit pattern as well as microvascular
architecture is very important for detecting early gastric
cancer and precancerous lesion [29].
Conclusions
Magnifying NBI endoscopy has advantages in the detec-
tion of some lesions with minute changes of gastric
mucosa pattern and capillary form, and facilitates the
diagnosis of early gastric cancer and precancerous gas-
tric lesions by identification and biopsy of the lesions.
Clearly, it can be used for the screening of early malig-
nancies of the stomach.
However, since the present study is uncontrolled, and
the number of cases is not big enough, a further pro-
spective, blinded study with a sufficient number of
patients who have or have no gastric carcinoma is
needed to assess the value of magnifying narrow-band
imaging in the diagnosis of precancerous lesions and
early gastric cancer in clinical practice.
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